Concepedia

Jaison Jose

JJ

3

Publications

1.3K

Citations

3

H-Index

2017

Active since

Affiliations

Novartis (United States)(Current)

Jaison Jose is an author at Novartis (United States) specializing in lung cancer, allergy, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2017–2018

3

Publications

3

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

, , +11

Anaphylaxis risk factors for hospitalization and intensive care: A comparison between adults and children in an upstate New York emergency department

Britta K. Sundquist, Jaison Jose, Daniel Pauze et al. · Allergy and Asthma Proceedings · 2018 · 24 citations · Full text

Evaluating satisfaction of patients with hereditary angioedema with their past and present treatments: Implications for future therapies

Jaison Jose, Erik Lehman, Timothy Craig · Allergy and Asthma Proceedings · 2017 · 22 citations

Rows per page

1–3 of 3